On August 29, 2019 Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, reported its participation at two upcoming healthcare conferences in September (Press release, Calithera Biosciences, AUG 29, 2018, View Source [SID1234535237]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 13th Annual Biotech Conference. Calithera will host meeting with investors at the conference in Boston on Wednesday, September 5, 2018.

Wells Fargo Securities 2018 Healthcare Conference. Susan M. Molineaux, Ph.D., the company’s Founder, President and Chief Executive Officer, will present in Boston on Thursday, September 6, at 8:00 a.m. Eastern Time.

The presentation will be webcast live, and available for replay, for up to 30 days at www.calithera.com in the Investor Relations section